HORIZON HEALTHCARE — All Prescriptions & Medications — Page 8
Practice Code: C82088 | LEICESTER, LE5 5UB
Showing results 351-400 of 564
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Safinamide | 33 | 1,000 | £2.2K | +63.8% ▲ |
| Nicotine | 33 | 2,519 | £1.1K | -41.6% ▼ |
| Co-trimoxazole(Trimethoprim/sulfamethoxazole) | 33 | 924 | £42 | -17.9% ▼ |
| Ibuprofen | 33 | 5,110 | £205 | -72.9% ▼ |
| Febuxostat | 33 | 840 | £65 | -11.6% ▼ |
| Chlorhexidine gluconate | 33 | 15.0K | £298 | +11.7% ▲ |
| 33 | 430 | £1.4K | +7.4% ▲ | |
| Fludrocortisone acetate | 32 | 1,914 | £267 | -69.7% ▼ |
| Mefenamic acid | 32 | 1,346 | £251 | -29.2% ▼ |
| Crotamiton | 31 | 3,690 | £211 | +86.4% ▲ |
| 31 | 3,100 | £81 | +140.3% ▲ | |
| 31 | 1,190 | £864 | +133.5% ▲ | |
| Dosulepin hydrochloride | 30 | 1,269 | £263 | -47.0% ▼ |
| Dutasteride | 30 | 900 | £51 | -41.6% ▼ |
| 30 | 940 | £4.3K | +114.5% ▲ | |
| Hydroxyzine hydrochloride | 29 | 1,344 | £42 | -45.6% ▼ |
| Denosumab | 29 | 29 | £7.7K | +6.6% ▲ |
| Sodium chloride | 29 | 3,266 | £301 | +22.5% ▲ |
| Ascorbic acid | 29 | 1,176 | £1.4K | +41.2% ▲ |
| Metronidazole | 29 | 1,205 | £292 | -22.8% ▼ |
| Aclidinium bromide/formoterol | 28 | 28 | £865 | -20.4% ▼ |
| Pimecrolimus | 28 | 1,220 | £734 | +65.4% ▲ |
| Salicylic acid | 28 | 208 | £106 | +121.4% ▲ |
| 28 | 1,738 | £211 | -43.3% ▼ | |
| Terbutaline sulphate | 27 | 28 | £221 | -50.2% ▼ |
| Vortioxetine | 27 | 476 | £449 | -61.1% ▼ |
| Cefalexin | 27 | 1,271 | £78 | -76.8% ▼ |
| Mycophenolate mofetil | 27 | 1,672 | £195 | -33.3% ▼ |
| Potassium chloride | 27 | 2,520 | £79 | +44.4% ▲ |
| RtS 2-2.4 kcal/ml m/sk higher protein,higher energy(0913011) | 27 | 357.4K | £3.8K | -38.3% ▼ |
| Indometacin | 27 | 2,704 | £474 | +71.6% ▲ |
| Adapalene | 27 | 1,890 | £656 | +23.4% ▲ |
| Hyoscine hydrobromide | 26 | 1,848 | £300 | -23.9% ▼ |
| Testosterone | 26 | 1,594 | £898 | -65.9% ▼ |
| Ready to serve 4.5 - 5 kcal/ml energy (fat) liquid (0913142) | 26 | 66.3K | £2.2K | +131.9% ▲ |
| Heparinoid | 26 | 3,995 | £221 | -0.9% vs avg |
| 26 | 924 | £264 | +34.5% ▲ | |
| 26 | 2,080 | £135 | -88.0% ▼ | |
| 26 | 1,085 | £138 | +97.1% ▲ | |
| Ergocalciferol | 25 | 720 | £98 | +49.3% ▲ |
| Powder extensively hydrolysed formula (0913101) | 25 | 34.4K | £957 | -65.3% ▼ |
| Baclofen | 25 | 15.4K | £148 | -87.5% ▼ |
| Betamethasone sodium phosphate | 25 | 245 | £68 | -3.5% ▼ |
| 25 | 1,880 | £3.7K | -48.7% ▼ | |
| Moxonidine | 24 | 840 | £135 | -56.9% ▼ |
| Insulin glulisine | 24 | 106 | £674 | +11.9% ▲ |
| Biphasic insulin lispro | 24 | 116 | £748 | -44.1% ▼ |
| Powder 1.6 kcal/ml milkshake (0913011) | 24 | 5,368 | £325 | -67.8% ▼ |
| Powder 20g protein equivalent (0913205) | 24 | 2,453 | £32.9K | +203.8% ▲ |
| Chlorhexidine gluconate | 24 | 7,200 | £47 | +9.3% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.